tradingkey.logo

IDEXX实验室

IDXX

535.265USD

+0.955+0.18%
交易中 美东报价延迟15分钟
43.22B总市值
48.29市盈率 TTM

IDEXX实验室

535.265

+0.955+0.18%
关于 IDEXX Laboratories Inc 公司
IDEXX Laboratories, Inc. 开发、生产和分销产品,并主要为伴侣动物兽医、牲畜和家禽、乳制品和水检测行业提供服务。该公司还提供人类医疗即时诊断和实验室诊断。其部门包括伴侣动物组 (CAG)、水质产品 (水) 以及牲畜、家禽和乳制品 (LPD)。CAG 部门为伴侣动物兽医行业提供基于诊断和信息管理的产品和服务,包括临床诊断解决方案、外部参考实验室服务以及兽医软件和服务。其水部门提供测试解决方案,用于准确检测和量化水中的各种微生物参数。其 LPD 部门提供诊断测试、服务和相关仪器,用于管理牲畜和家禽的健康状况,以提高牛奶的质量和安全性。
公司简介
公司代码IDXX
公司名称IDEXX Laboratories Inc
上市日期Jun 21, 1991
成立日期1983
CEOMr. Andrew Emerson
员工数量11000
证券类型Ordinary Share
年结日Jun 21
公司地址One Idexx Drive
城市WESTBROOK
上市交易所NASDAQ Global Select Consolidated
国家United States of America
邮编04092-2041
电话12075560300
网址https://www.idexx.com/
公司代码IDXX
上市日期Jun 21, 1991
成立日期1983
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Michael Erickson, Ph.D.
Mr. Michael Erickson, Ph.D.
Executive Vice President and General Manager, Point of Care Diagnostics and Telemedicine
Executive Vice President and General Manager, Point of Care Diagnostics and Telemedicine
12.58K
+18.05%
Dr. Sophie V. Vandebroek, Ph.D.
Dr. Sophie V. Vandebroek, Ph.D.
Independent Director
Independent Director
8.69K
+3.11%
Mr. Lawrence D. (Larry) Kingsley
Mr. Lawrence D. (Larry) Kingsley
Independent Chairman of the Board
Independent Chairman of the Board
8.23K
+4.39%
Mr. Michael J. Lane
Mr. Michael J. Lane
Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology
Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology
7.70K
+0.61%
Ms. Sharon E. Underberg
Ms. Sharon E. Underberg
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
5.93K
+8.90%
Mr. Daniel M. (Dan) Junius
Mr. Daniel M. (Dan) Junius
Independent Director
Independent Director
3.00K
+9.56%
Mr. Andrew Emerson
Mr. Andrew Emerson
Executive Vice President, Chief Executive Officer, Treasurer
Executive Vice President, Chief Executive Officer, Treasurer
2.40K
--
Mr. Michael Schreck
Mr. Michael Schreck
Executive Vice President and General Manager, Veterinary Software and Services, Corporate Accounts and Customer Experience
Executive Vice President and General Manager, Veterinary Software and Services, Corporate Accounts and Customer Experience
1.92K
+112.86%
Mr. Bruce L. Claflin
Mr. Bruce L. Claflin
Independent Director
Independent Director
1.72K
--
Dr. Stuart M. Essig, Ph.D.
Dr. Stuart M. Essig, Ph.D.
Independent Director
Independent Director
1.09K
+31.76%
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Michael Erickson, Ph.D.
Mr. Michael Erickson, Ph.D.
Executive Vice President and General Manager, Point of Care Diagnostics and Telemedicine
Executive Vice President and General Manager, Point of Care Diagnostics and Telemedicine
12.58K
+18.05%
Dr. Sophie V. Vandebroek, Ph.D.
Dr. Sophie V. Vandebroek, Ph.D.
Independent Director
Independent Director
8.69K
+3.11%
Mr. Lawrence D. (Larry) Kingsley
Mr. Lawrence D. (Larry) Kingsley
Independent Chairman of the Board
Independent Chairman of the Board
8.23K
+4.39%
Mr. Michael J. Lane
Mr. Michael J. Lane
Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology
Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology
7.70K
+0.61%
Ms. Sharon E. Underberg
Ms. Sharon E. Underberg
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
5.93K
+8.90%
Mr. Daniel M. (Dan) Junius
Mr. Daniel M. (Dan) Junius
Independent Director
Independent Director
3.00K
+9.56%
收入明细
单位: USD更新时间: 7月6日 周日
单位: USD更新时间: 7月6日 周日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
业务USD
名称
营收
占比
CAG Diagnostics recurring revenue
806.27M
80.75%
IDEXX VetLab consumables
344.78M
34.53%
Reference laboratory diagnostic and consulting services
344.41M
34.49%
Rapid assay products
84.03M
8.42%
Veterinary software, services and diagnostic imaging systems
81.58M
8.17%
Other
-662.63M
-66.37%
地区USD
名称
营收
占比
United States
654.86M
65.59%
Europe & Middle East & Africa (EMEA) (Region)
204.55M
20.49%
Asia Pacific
81.73M
8.19%
Canada
37.30M
3.74%
Latin America
19.99M
2.00%
业务
地区
业务USD
名称
营收
占比
CAG Diagnostics recurring revenue
806.27M
80.75%
IDEXX VetLab consumables
344.78M
34.53%
Reference laboratory diagnostic and consulting services
344.41M
34.49%
Rapid assay products
84.03M
8.42%
Veterinary software, services and diagnostic imaging systems
81.58M
8.17%
Other
-662.63M
-66.37%
股东统计
更新时间: 7月24日 周四
更新时间: 7月24日 周四
持股股东
股东类型
持股股东
持股股东
占比
The Vanguard Group, Inc.
12.21%
BlackRock Institutional Trust Company, N.A.
6.76%
State Street Global Advisors (US)
4.54%
Fundsmith LLP
3.29%
Geode Capital Management, L.L.C.
3.00%
Other
70.20%
持股股东
持股股东
占比
The Vanguard Group, Inc.
12.21%
BlackRock Institutional Trust Company, N.A.
6.76%
State Street Global Advisors (US)
4.54%
Fundsmith LLP
3.29%
Geode Capital Management, L.L.C.
3.00%
Other
70.20%
股东类型
持股股东
占比
Investment Advisor
56.49%
Investment Advisor/Hedge Fund
29.33%
Research Firm
3.99%
Pension Fund
2.25%
Bank and Trust
2.04%
Hedge Fund
1.86%
Sovereign Wealth Fund
1.32%
Individual Investor
0.68%
Family Office
0.48%
Other
1.57%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
2259
79.04M
98.28%
-694.13K
2025Q1
2279
79.02M
98.21%
-512.23K
2024Q4
2242
76.14M
93.59%
-5.30M
2024Q3
2152
77.90M
94.66%
-4.67M
2024Q2
2140
80.09M
96.98%
-924.14K
2024Q1
2154
77.56M
93.40%
-2.57M
2023Q4
2187
77.94M
93.84%
-2.83M
2023Q3
2153
79.23M
95.34%
-677.16K
2023Q2
2157
77.53M
93.40%
-1.56M
2023Q1
2158
77.14M
92.96%
-2.07M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
The Vanguard Group, Inc.
9.82M
12.21%
+146.37K
+1.51%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
5.44M
6.76%
+113.70K
+2.14%
Mar 31, 2025
State Street Global Advisors (US)
3.65M
4.54%
+12.32K
+0.34%
Mar 31, 2025
Fundsmith LLP
2.65M
3.29%
-14.52K
-0.55%
Mar 31, 2025
Geode Capital Management, L.L.C.
2.41M
3%
+112.62K
+4.90%
Mar 31, 2025
Baron Capital Management, Inc.
2.06M
2.56%
+54.26K
+2.71%
Mar 31, 2025
T. Rowe Price Associates, Inc.
1.87M
2.33%
+824.75K
+78.91%
Mar 31, 2025
Invesco Capital Management (QQQ Trust)
1.66M
2.07%
-25.31K
-1.50%
Jun 30, 2025
BlackRock Asset Management Ireland Limited
1.14M
1.42%
+15.87K
+1.41%
Mar 31, 2025
Principal Global Investors (Equity)
1.13M
1.4%
+414.80K
+58.32%
Mar 31, 2025
查看更多
持股ETF
更新时间: 7月6日 周日
更新时间: 7月6日 周日
机构名称
占比
ProShares Pet Care ETF
9.86%
First Trust Water ETF
4.85%
iShares U.S. Medical Devices ETF
4.46%
First Trust S&P 500 Economic Moat Index ETF
2.42%
Adaptive Core ETF
2.35%
Invesco S&P 500 Equal Weight Health Care ETF
2.14%
Putnam Sustainable Future ETF
1.99%
American Century Mid Cap Growth Impact ETF
1.93%
SPDR S&P Health Care Equipment ETF
1.85%
Tema Durable Quality ETF
1.83%
查看更多
ProShares Pet Care ETF
占比9.86%
First Trust Water ETF
占比4.85%
iShares U.S. Medical Devices ETF
占比4.46%
First Trust S&P 500 Economic Moat Index ETF
占比2.42%
Adaptive Core ETF
占比2.35%
Invesco S&P 500 Equal Weight Health Care ETF
占比2.14%
Putnam Sustainable Future ETF
占比1.99%
American Century Mid Cap Growth Impact ETF
占比1.93%
SPDR S&P Health Care Equipment ETF
占比1.85%
Tema Durable Quality ETF
占比1.83%
分红派息
近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
tradingkey.logo
tradingkey.logo
日内数据由路孚特(Refinitiv)提供,并受使用条款约束。历史及当前收盘数据均由路孚特提供。所有报价均以当地交易所时间为准。美股报价的实时最后成交数据仅反映通过纳斯达克报告的交易。日内数据延迟至少15分钟或遵循交易所要求。
* 参考、分析和交易策略由第三方提供商Trading Central提供,观点基于分析师的独立评估和判断,未考虑投资者的投资目标和财务状况。
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有
KeyAI